RNA Clinical Trials Solutions
-
Site Management Organization
11/7/2023
Discover the power of clinical excellence with Acrostar's SMO Division, a dedicated entity operating as part of Novotech.
-
The Future Of Reimbursement For Cell & Gene Therapies
7/27/2022
Our team excels at understanding the ever-changing and complex healthcare market and helping clients solve issues. Learn about the payer challenges, potential reimbursements, and the competition to consider.
-
Oncology CRO Services
6/27/2023
Biotechnology companies are facing increased challenges around participant recruitment and retention, lengthy timeframes, and relatively high costs.
-
Orphan And Rare Disease CRO Services
11/7/2023
Rare Disease clinical studies demand a specialized full-service CRO with expertise in enrollment, site selection, and global regulatory knowledge, including access to patient registries for accelerated recruitment.
-
Real World Data
6/27/2023
Accelerate patient recruitment and drug development with real world data (RWD).
-
Infectious Diseases And Vaccines CRO Services
6/27/2023
Many biotechnology companies look at the Asia-Pacific region for their trials in Infectious diseases and Vaccines due to the high prevalence of diseases such as Hepatitis (Hepatitis B, Hepatitis C), HIV, and Influenza across the region.
-
Patient Recruitment And Site Selection
12/20/2022
Novotech relies on years of experience, in-country knowledge, and real-life big data to identify and propose the best-performing sites. Uncover the possibilities for your next study.
-
New Next-Generation GMP Facility
5/16/2023
A new state-of-the-art GMP facility has been created to accelerate the development of CRISPR-based cell and gene therapies, overcoming challenges such as procuring reliable GMP-grade sgRNA persist.
-
Recruit Patients Faster In The Asia-Pacific Region
9/29/2022
Novotech relies on years of experience, in-country knowledge and real-life big data to identify and propose the best-performing sites and investigators for your study.
-
Oncology CRO Services
11/7/2023
Biotechnology companies are facing increased challenges around participant recruitment and retention, lengthy timeframes and relatively high costs.